GSK Wins FDA Approval for Hepatitis B Drug

โฎ BeforeFewer hepatitis B patients could reach a functional cure with earlier methods.
โ
NowWith FDA approval, far more patients can be considered for a functional cure.
In short
- The US Food and Drug Administration has approved GSK's hepatitis B drug.
- The source says the drug extends functional cures to far more patients than previous methods.
- Functional cure means the virus is controlled after treatment, without continuing treatment.
Why the Good News Desk likes this one
The approval gives doctors a new option for treating hepatitis B. The source says it reaches far more patients than previous methods. The source does not give trial details or patient numbers, so the scale of the change is not yet clear.
Advertisement
From STAT
GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous methods.
Ask this story
Next in today's ten
Advertisement
